Stephanie Sandberg, DO
Surgery · O Fallon, MONPI 1649273160
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.6%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Misonix Inc at 50.8% of the total. Reporting peaked in 2019 at $2,549 and has fallen 85.8% since, to $361 in 2025.
Across 105 payments — averaging $49.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Misonix Inc$3K
- Organogenesis Inc.$789
- Kerecis Limited$354
- Integra Lifesciences Corporation$325
- Koya Medical, Inc.$257
- Smith+Nephew$186
- plus $648 from 14 others
What the payments were for
- Consulting fees$50010%
- Speaking & faculty fees$2,11841%
- Food & beverage$2,58050%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Misonix Inc | 5 | $2,640 |
| Organogenesis Inc. | 42 | $789 |
| Kerecis Limited | 8 | $354 |
| Integra Lifesciences Corporation | 16 | $325 |
| Koya Medical, Inc. | 2 | $257 |
| Smith+Nephew | 10 | $186 |
| Davol Inc. | 2 | $178 |
| Covidien LP | 1 | $85 |
| Lifenet Health | 4 | $64 |
| AbbVie | 2 | $61 |
| KCI USA, Inc. | 2 | $33 |
| Hologic Sales And Service, LLC | 1 | $32 |
| Shockwave Medical, Inc | 1 | $32 |
| Aroa Biosurgery Incorporated | 2 | $30 |
| Tactile Systems Technology Inc | 2 | $27 |
| Bioventus LLC | 1 | $24 |
| Hartmann USA, Inc. | 1 | $22 |
| Convatec Inc. | 1 | $22 |
| Solventum Corporation | 1 | $19 |
| Acera Surgical, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,199 in reported general payments places this provider in the 70th percentile of 612 surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 13 | $832 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 51 | $224 |
| Mupirocin | 12 | $111 |
| Doxycycline Hyclate | 12 | $105 |
| Tramadol Hcl | 19 | $39 |
| Ondansetron Hcl | 24 | $32 |
Paid to pharmacies, not to this prescriber.
Other surgery in O Fallon
- James ScottSaint Louis$307K
- Omar GuerraSaint Louis$249K
- John TannColumbia$216K
- Mark DrakeSaint Louis$212K
- Adeel KhanSaint Louis$204K
- Michael AwadSaint Louis$176K
- Patricia HodginsFenton$145K
- Laurie PunchSaint Louis$141K
- Jeffrey BlatnikSaint Louis$134K
- Bradley MooreKansas City$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.